KALLMAN et al v. ARONCHICK et al
ORDER THAT DR. ARONCHICH IS DISMISSED FROM THIS ACTION. DR. ARONCHICK'S MOTION TO DISMISS IS DENIED AS MOOT. THE CLERK OF COURT SHALL TRANSFER THIS CASE TO THE DISTRICT OF NEW JERSEY. BECAUSE THIS CASE IS BEING TRANSFERRED TO THE DISTRICT OF NEW JERSEY, SALIX DEFENDANTS PENDING MOTIONS TO DISMISS AND INKINE'S PENDING MOTION TO DISMISS ARE DENIED WITHOUT PREJUDICE; ETC.. SIGNED BY HONORABLE ROBERT F. KELLY ON 11/8/13. 11/8/13 ENTERED AND E-MAILED.(jl, )
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
MURIAL KALLMAN and
CRAIG ARONCHICK, M.D., et al.,
AND NOW, this 8th day of November, 2013, upon consideration of Plaintiffs, Murial
Kallman and Stanley Kallman’s (“Plaintiffs”), Motion to Remand (Doc. No. 8), Defendants,
Craig Aronchick, M.D. (“Dr. Aronchick”), Salix Pharmaceuticals, Inc., Salix Pharmaceuticals,
Ltd. (“Salix Defendants”), and InKine Pharmaceutical Company, Inc.’s (“InKine”), Response,
and Plaintiffs’ Reply, it is hereby ORDERED that the Motion is DENIED. It is further
1. Dr. Aronchick is DISMISSED from this action;
2. Dr. Aronchick’s Motion to Dismiss (Doc. No. 17) is DENIED as moot;
3. The Clerk of Court shall TRANSFER this case to the District of New Jersey; and
4. Because this case is being transferred to the District of New Jersey, Salix Defendants’
pending Motions to Dismiss (Doc. Nos. 6, 15) and InKine’s pending Motions to Dismiss
(Doc. Nos. 7, 16) are DENIED WITHOUT PREJUDICE to be re-filed in the District of
New Jersey if the parties so desire.
BY THE COURT:
/s/ Robert F. Kelly
ROBERT F. KELLY
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?